Last week, something happened in my clinic that left me pondering deeply about the parallels between treating infertility and investing in startups. A patient of mine, let’s call her Meera, came in for a follow-up. Her IVF journey had been fraught with challenges, and despite the odds, she remained steadfast in her resolve. As we discussed her progress, she candidly shared her experience of dealing with assumptions—her own, her family’s, even mine as her doctor. It struck me that her insights had a lot in common with the world of startups.
In the startup ecosystem, assumptions are aplenty. Founders often assume they know what their customers want, just as doctors sometimes assume they know what’s best for their patients. But, as both an IVF specialist and an angel investor, I’ve learned that assumptions can be treacherous. They’re the silent saboteurs lurking in the shadows, waiting to dismantle the best-laid plans. Meera’s journey was a stark reminder of why testing assumptions is vital, whether you’re trying to create life or build a business.
In the world of entrepreneurship, the process of assumption testing is often discussed but not frequently practiced with the rigor it deserves. I’ve seen startups burn through resources, time, and energy, only to realize they’ve been building a solution to a problem that doesn’t exist. This is a costly oversight, one that could be avoided with a disciplined approach to validating assumptions.
Assumption testing can be distilled into a few critical steps. First, identify your assumptions. This may sound simple, but it requires a deep understanding of your customer and the problem you’re trying to solve. In my experience, startups often skip this step in their eagerness to get a product to market. But without a clear grasp of your assumptions, you’re navigating blindfolded.
Once you’ve identified your assumptions, the next step is to test them. This doesn’t have to be a complex or expensive process. It can be as straightforward as conducting customer interviews or running a small-scale pilot. The key is to gather insights quickly and efficiently, so you can either validate your assumptions or pivot towards a different direction.
Here’s where the parallels with IVF become clear. In medicine, we don’t just assume a treatment will work; we test and retest until we find the right approach for each individual patient. Similarly, in startups, the faster you invalidate a faulty assumption, the sooner you can pivot toward a viable solution. This iterative process is crucial, yet it’s often neglected in the rush to scale.
In Meera’s case, her perseverance taught me that the journey of assumption testing is not just about identifying what’s wrong but also about understanding why it’s wrong. Her strength reminded me of the resilience required in both domains. The emotional toll of IVF is not unlike the rollercoaster ride of entrepreneurship. Both require a tenacity that goes beyond the ordinary.
This brings me to the heart of what Meera’s experience illuminated for me—an insight that many founders and investors tend to overlook. The real value in assumption testing isn’t just in the results; it’s in the process itself. It’s about the learning, the insights gained, and the deeper understanding of your customers or patients. This is where the true innovation lies.
In the startup world, there’s a tendency to celebrate the end result—the successful product launch, the funding round. But what’s often missed is the value of the journey itself. The insights gained from invalidating an assumption can be far more valuable than the assumption itself. They can lead to breakthroughs, innovations, and the kind of customer understanding that sets successful companies apart.
In my clinic, when a patient like Meera shows resilience in the face of adversity, it’s a reminder of the importance of the journey. Her ability to confront assumptions and adapt accordingly is something every founder can learn from. It’s this resilience that I believe every startup founder needs—much like the resilience of an IVF patient.
As I reflect on these parallels, I’m reminded of the importance of humility in both medicine and entrepreneurship. It’s easy to become complacent, to rely on past successes and assume they’ll translate into future wins. But the truth is, in both fields, every new challenge requires a fresh approach, a willingness to learn and adapt.
In conclusion, Meera’s journey was a reminder that in both startups and IVF, assumptions are not to be feared, but to be confronted. They are opportunities for learning, for growth, and for innovation. And it’s in this process of testing and iterating that we find the true path to success.
So, to my fellow founders and investors, I urge you to embrace the uncertainty of assumptions. Test them rigorously, learn from them, and let them guide you to the breakthroughs that lie just beyond the horizon. And remember, much like in the journey of IVF, it’s the resilience in the face of uncertainty that often defines the greatest successes.